Author Interviews, NEJM, OBGYNE / 05.01.2022
Abortion Pill: Canadian Study Finds No Increase in Complications After Removing Restrictions
MedicalResearch.com Interview with:
Laura Schummers, ScD (she/her/hers)
Postdoctoral Fellow, Contraception and Abortion Research Team
CIHR Patient-Oriented Research Leadership Fellow
Post-doctoral Trainee, ICES McMaster
UBC - Department of Family Practice | Women's Health Research Institute
MedicalResearch.com: What is the background for this study?
Response: Canada was the first country in the world to remove all supplemental restrictions on the dispensing and administration of mifepristone, making the drug available as a normal prescription. This meant that the abortion pill could be prescribed by any doctor or nurse practitioner, dispensed by any pharmacist, and taken by patients when, where and if they choose.
(more…)